Agilent Touts 'Substantial' Market Potential of Impending Target-Enrichment Kit
February 10, 2009
Agilent Touts 'Substantial' Market Potential of Impending Target-Enrichment Kit
The company will make its debut in the target-enrichment market on the heels of Roche NimbleGen, which markets an array-based sequence-capture kit, and Raindance Technologies, which last week launched an in-solution sequence-enrichment product.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NIH Team Presents Findings from Fungi-focused Study of Skin Microbiome
May 22, 2013 / GenomeWeb Daily News - Researchers ID Colorectal Cancer Subtypes through Expression Profiling; Prognostic Value Noted
May 22, 2013 / GenomeWeb Daily News - At Investor Confab, Illumina Details 'Enormous' DTC Demand as Market Shifts to Less Complex Chips
May 21, 2013 / BioArray News - ICCG, Awaiting Funding, Moves Ahead with Plans to Build Database of Genomic, Phenotypic Information
May 21, 2013 / BioArray News - Q&A: INMEGEN's Alfredo Hidalgo on Using Genomics to Address Mexico's Most Pressing Health Problems
May 21, 2013 / BioArray News